Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 29;28(2):298–307. doi: 10.1158/1078-0432.CCR-21-2007

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2021 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 1. Tumor response assessed by local RECIST, treatment duration, and disposition for patients with TGCT. Data cutoff: January 31, 2018. Each line represents 1 patient in the study. Patients received an initial dose of 1,000 mg/day. Treatment duration in months is calculated as treatment duration in days divided by 30.4167. RECIST, Response Evaluation Criteria in Solid Tumors; TGCT, tenosynovial giant cell tumor. — Tumor response assessed by local RECIST, treatment duration, and disposition for patients with TGCT. Data cutoff: January 31, 2018. Each line represents 1 patient in the study. Patients received an initial dose of 1,000 mg/day. Treatment duration in months is calculated as treatment duration in days divided by 30.4167. RECIST, Response Evaluation Criteria in Solid Tumors; TGCT, tenosynovial giant cell tumor.